The vaccine, still in the final federal approval process, has fewer handling restrictions than the Pfizer and Moderna vaccines now being used.
Those vaccines require two doses to be fully effective and must be stored at extremely low temperatures.
The vaccine, still in the final federal approval process, has fewer handling restrictions than the Pfizer and Moderna vaccines now being used.
Those vaccines require two doses to be fully effective and must be stored at extremely low temperatures.
The U.S. Food and Drug Administration has given the greenlight to Johnson & Johnson's single-shot COVID-19 vaccine.
Johnson & Johnson’s coronavirus vaccine is nearing the end of the FDA approval process. WBZ-TV's Mike LaCrosse reports.